European trade association calls for medical imaging equipment to be replaced

COCIR, a European trade association for the medical imaging, health IT and electromedical industries, has released a poster showing Europe’s medical imaging equipment is in desperate need of being replaced. The poster, which can be viewed online, was first displayed at the European Congress of Radiology.

“A quarter of the European CT installed base cannot be upgraded with the most important dose-saving technology advances, CT Dose Modulation and CT Reiterative reconstruction algorithm technologies,” Nicole Denjoy, COCIR secretary general, said in a prepared statement. “This is equivalent to approximately 2,500 units in Western Europe and 500 in Eastern Europe, which can now be considered inadequate from a radiation safety perspective. They should be replaced as a matter of urgency.”

According to the COCIR’s country-by-country research of Western Europe, 26 percent of Germany’s medical imaging equipment needs replaced. In Italy, the number is 25 percent, and in Spain, it is 14 percent.

Looking at data from Eastern Europe, 40 percent of Poland’s equipment needs replaced, along with 18 percent of Romania’s and 12 percent of Czech Republic’s equipment.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.